Association of EZH2 Genotypes With Oral Cancer Risk

被引：1

作者：

Shih, Liang-Chun ^{[1
]}

Tsai, Chia-Wen ^{[2
,3
]}

Lin, Tzu-Chieh ^{[4
,5
]}

Wang, Yun-Chi ^{[2
,3
]}

He, Jie-Long ^{[6
]}

Hsu, Che-Lun ^{[7
]}

Hsia, Te-Chun ^{[3
]}

Tsai, Fuu-Jen ^{[8
]}

Yang, Jai-Sing ^{[8
]}

Hsu, Yuan-Man ^{[8
]}

Bau, Da-Tian ^{[2
,3
,9
,10
]}

Chang, Wen-Shin ^{[2
,3
,10
]}

机构：

[1] China Med Univ Hosp, Dept Otorhinolaryngol, Taichung, Taiwan

[2] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan

[3] China Med Univ Hosp, Dept Med Res, Terry Fox Canc Res Lab, Taichung, Taiwan

[4] Taichung Vet Gen Hosp, Dept Emergency Med, Taichung, Taiwan

[5] Tunghai Univ, Coll Fine Arts & Creat Design, Taichung, Taiwan

[6] Asia Univ, Dept Post Baccalaureate Vet Med, Taichung, Taiwan

[7] Asia Univ Hosp, Dept Otorhinolaryngol, Taichung, Taiwan

[8] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan

[9] Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan

[10] China Med Univ Hosp, Dept Med Res, Terry Fox Canc Res Lab, 2 Yuh Der Rd, Taichung 404, Taiwan

来源：

IN VIVO | 2022年 / 36卷 / 06期

关键词：

Enhancer of zeste homolog 2 (EZH2); genotype; oral cancer; single nucleotide polymorphism; Taiwan; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR-CELL PROLIFERATION; HOMOLOG; EXPRESSION; BETEL QUID; HISTONE METHYLTRANSFERASE; POLYCOMB PROTEIN; ZESTE HOMOLOG-2; BREAST-CANCER; EZH2; SMOKING;

D O I：

10.21873/invivo.13002

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Background/Aim: The over-expression of enhancer of zeste homolog 2 (EZH2) protein is found in oral cancer tissues. However, the genetic role of the enhancer of EZH2 in the etiology of oral cancer is unknown. The aim of this study was to evaluate the association of EZH2 genotypes with oral cancer risk among Taiwanese. Materials and Methods: Three polymorphic variants of EZH2, rs887569 (C to T), rs41277434 (A to C), and rs3757441 (T to C), were analyzed regarding their association with oral cancer risk among 958 oral cancer patients and the same number of healthy controls by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). In addition, the interaction of EZH2 rs887569, rs41277434, and rs3757441 genotypes with personal behaviors such as smoking, alcohol drinking, and betel quid chewing were also examined.

引用

页码：2669 / 2677

页数：9

共 50 条

[1] Association of Enhancer of Zeste 2 (EZH2) Genotypes with Bladder Cancer Risk in Taiwan
Chang, Wen-Shin
Liao, Cheng-Hsi
Tsai, Chia-Wen
Hu, Pei-Shin
Wu, Hsi-Chin
Hsu, Shih-Wei
Hsiao, Chieh-Lun
Hsu, Chang-Hsien
Hung, Yi-Wen
Bau, Da-Tian
[J]. ANTICANCER RESEARCH, 2016, 36 (09) : 4509 - 4514
[2] Significant association of enhancer of zeste 2 (EZH2) genotypes with bladder cancer risk in Taiwan
Liao, Cheng-Hsi
Chang, Wen-Shin
Wu, Hsi-Chin
Tsai, Chia-Wen
Bau, Da-Tian
[J]. INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 : 324 - 324
[3] Association between EZH2 polymorphisms and colorectal cancer risk in Han Chinese population
Jian Wang
Zhen-Bin Ma
Kun Li
Guang-Hong Guo
[J]. Medical Oncology, 2014, 31
[4] Association between EZH2 polymorphisms and colorectal cancer risk in Han Chinese population
Wang, Jian
Ma, Zhen-Bin
Li, Kun
Guo, Guang-Hong
[J]. MEDICAL ONCOLOGY, 2014, 31 (03)
[5] Targeting EZH2 in cancer
Kimberly H Kim
Charles W M Roberts
[J]. Nature Medicine, 2016, 22 : 128 - 134
[6] Aberrations of EZH2 in Cancer
Chase, Andrew
Cross, Nicholas C. P.
[J]. CLINICAL CANCER RESEARCH, 2011, 17 (09) : 2613 - 2618
[7] Targeting EZH2 in cancer
Kim, Kimberly H.
Roberts, Charles W. M.
[J]. NATURE MEDICINE, 2016, 22 (02) : 128 - 134
[8] A rare variant in EZH2 is associated with prostate cancer risk
Raspin, Kelsie
FitzGerald, Liesel M.
Marthick, James R.
Field, Matt A.
Malley, Roslyn C.
Banks, Annette
Donovan, Shaun
Thomson, Russell J.
Foley, Georgea R.
Stanford, Janet L.
Dickinson, Joanne L.
[J]. INTERNATIONAL JOURNAL OF CANCER, 2021, 149 (05) : 1089 - 1099
[9] Targeting EZH2 in cancer therapy
Yamagishi, Makoto
Uchimaru, Kaoru
[J]. CURRENT OPINION IN ONCOLOGY, 2017, 29 (05) : 375 - 381
[10] EZH2: An Accomplice of Gastric Cancer
Yu, Wuhan
Liu, Ning
Song, Xiaogang
Chen, Lang
Wang, Mancai
Xiao, Guohui
Li, Tengfei
Wang, Zheyuan
Zhang, Youcheng
[J]. CANCERS, 2023, 15 (02)

← 1 2 3 4 5 →